David Sharon

3.1k total citations
66 papers, 2.2k citations indexed

About

David Sharon is a scholar working on Molecular Biology, Global and Planetary Change and Genetics. According to data from OpenAlex, David Sharon has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Global and Planetary Change and 10 papers in Genetics. Recurrent topics in David Sharon's work include Climate variability and models (10 papers), Virus-based gene therapy research (8 papers) and Aeolian processes and effects (8 papers). David Sharon is often cited by papers focused on Climate variability and models (10 papers), Virus-based gene therapy research (8 papers) and Aeolian processes and effects (8 papers). David Sharon collaborates with scholars based in Canada, Israel and United States. David Sharon's co-authors include Uri Dayan, Baruch Ziv, Yehouda Enzel, H. Kutiel, Rivka Amit, Ron Kahana, Onn Crouvi, Revital Bookman, Mordechai Stein and Haim Gvirtzman and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

David Sharon

63 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sharon Canada 23 891 709 345 321 314 66 2.2k
Antonio Cendrero Spain 28 674 0.8× 665 0.9× 584 1.7× 68 0.2× 260 0.8× 62 2.9k
Christian Pfister France 43 2.8k 3.2× 2.5k 3.5× 180 0.5× 372 1.2× 381 1.2× 268 6.2k
Yafeng Shi China 24 2.9k 3.2× 1.3k 1.8× 693 2.0× 141 0.4× 611 1.9× 81 3.9k
Joyce Bosmans Netherlands 18 817 0.9× 858 1.2× 210 0.6× 81 0.3× 399 1.3× 25 2.0k
Li Wu China 19 482 0.5× 346 0.5× 156 0.5× 118 0.4× 381 1.2× 67 1.3k
Alain Demoulin Belgium 23 665 0.7× 370 0.5× 319 0.9× 107 0.3× 200 0.6× 90 1.9k
Robert J. Oglesby United States 36 2.4k 2.7× 1.7k 2.3× 451 1.3× 53 0.2× 347 1.1× 106 3.4k
Michael M. McGlue United States 24 650 0.7× 212 0.3× 432 1.3× 48 0.1× 690 2.2× 80 1.6k
Grace S. Brush United States 30 788 0.9× 1.1k 1.5× 463 1.3× 83 0.3× 1.7k 5.3× 47 3.7k
Martin J. Hodson United Kingdom 32 684 0.8× 110 0.2× 125 0.4× 173 0.5× 506 1.6× 82 4.2k

Countries citing papers authored by David Sharon

Since Specialization
Citations

This map shows the geographic impact of David Sharon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sharon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sharon more than expected).

Fields of papers citing papers by David Sharon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sharon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sharon. The network helps show where David Sharon may publish in the future.

Co-authorship network of co-authors of David Sharon

This figure shows the co-authorship network connecting the top 25 collaborators of David Sharon. A scholar is included among the top collaborators of David Sharon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sharon. David Sharon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tahir, Stephen K., Emiliano Calvo, Benedito A. Carneiro, et al.. (2023). Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood. 141(17). 2114–2126. 9 indexed citations
2.
Sharon, David, et al.. (2023). Huntingtin S421 phosphorylation increases kinesin and dynein engagement on early endosomes and lysosomes. Biophysical Journal. 122(7). 1168–1184. 6 indexed citations
3.
Farnós, Omar, et al.. (2023). Targeted Delivery of Chimeric Antigen Receptor into T Cells via CRISPR-Mediated Homology-Directed Repair with a Dual-AAV6 Transduction System. Current Issues in Molecular Biology. 45(10). 7705–7720. 4 indexed citations
4.
Armstrong, Heather, Heekuk Park, David Sharon, et al.. (2023). Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10−/− mouse model of inflammatory bowel disease. Microbiome. 11(1). 39–39. 6 indexed citations
5.
Sharon, David, et al.. (2022). An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia. PLoS Computational Biology. 18(9). e1010439–e1010439. 2 indexed citations
6.
Liu, Qiang, David Sharon, Séverine Cathelin, et al.. (2021). Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis. Cell stem cell. 28(10). 1851–1867.e8. 56 indexed citations
7.
Sharon, David, et al.. (2021). A mean-field approach for modeling the propagation of perturbations in biochemical reaction networks. European Journal of Pharmaceutical Sciences. 165. 105919–105919. 2 indexed citations
8.
Sharon, David, et al.. (2020). A pooled genome-wide screening strategy to identify and rank influenza host restriction factors in cell-based vaccine production platforms. Scientific Reports. 10(1). 12166–12166. 19 indexed citations
9.
Sharon, David & Steven M. Chan. (2019). Application of CRISPR-Cas9 Screening Technologies to Study Mitochondrial Biology in Healthy and Disease States. Advances in experimental medicine and biology. 1158. 269–277. 2 indexed citations
10.
Cathelin, Séverine, David Sharon, Dan Cojocari, et al.. (2018). Combination of Enasidenib and Venetoclax Shows Superior Anti-Leukemic Activity Against IDH2 Mutated AML in Patient-Derived Xenograft Models. Blood. 132(Supplement 1). 562–562. 23 indexed citations
11.
12.
Chaurasiya, Shyambabu, David Sharon, Kyle Potts, et al.. (2016). Breast cancer gene therapy using an adenovirus encoding human IL-2 under control of mammaglobin promoter/enhancer sequences. Cancer Gene Therapy. 23(6). 178–187. 18 indexed citations
13.
Zhang, Guangzhi, David Sharon, Juan Jovel, et al.. (2015). Pericentriolar Targeting of the Mouse Mammary Tumor Virus GAG Protein. PLoS ONE. 10(6). e0131515–e0131515. 9 indexed citations
14.
Sharon, David, et al.. (2013). 2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells. PLoS ONE. 8(6). e65222–e65222. 7 indexed citations
15.
16.
Wang, Peng, Fang Wu, Xiaoxia Ye, et al.. (2012). The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma. Cellular Signalling. 24(10). 1955–1963. 9 indexed citations
17.
Gélébart, Pascal, Mona Anand, David Sharon, et al.. (2012). Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma. Blood Cancer Journal. 2(8). e82–e82. 32 indexed citations
18.
Amit, Rivka, Yehouda Enzel, & David Sharon. (2006). Permanent Quaternary hyperaridity in the Negev, Israel, resulting from regional tectonics blocking Mediterranean frontal systems. Geology. 34(6). 509–509. 80 indexed citations
19.
Ziv, Baruch, Uri Dayan, & David Sharon. (2004). A mid-winter, tropical extreme flood-producing storm in southern Israel: Synoptic scale analysis. Meteorology and Atmospheric Physics. 88(1-2). 53–63. 75 indexed citations
20.
Sharon, David, et al.. (2000). The study of rainfall distributions in small watersheds in Israel: from early observations to model simulations.. IAHS-AISH publication. 13–28. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Cendrero Breakdown of academic impact, for papers by Christian Pfister Breakdown of academic impact, for papers by Yafeng Shi Breakdown of academic impact, for papers by Joyce Bosmans Breakdown of academic impact, for papers by Li Wu Breakdown of academic impact, for papers by Alain Demoulin Breakdown of academic impact, for papers by Robert J. Oglesby Breakdown of academic impact, for papers by Michael M. McGlue Breakdown of academic impact, for papers by Grace S. Brush Breakdown of academic impact, for papers by Martin J. Hodson
Rankless by CCL
2026